Immatics at the Keystone Symposium “Antibodies as Drugs” (Feb 2-6) in Santa Fe, NM (USA)

| News, USA

Discovery, Translation, Commercialization: Developing CAR-T into viable, accessible therapies

Meet Immatics at the Keystone Symposium “Antibodies as Drugs” in Santa Fe, New Mexico, and deep dive with us into the exciting field of antibody driven sciences: From basic to translational to clinical for the benefit of patients!

 

Wednesday, Feb 5, 5pm – 7pm 

Plenary PM: T Cell Targeting for Cancer Therapy

TCR-Based Cancer Immunotherapies to Novel pMHC Targets

Speaker: Amir Alpert, Assoc. Director Immunology  

 

We are looking forward to seeing you there.

Further information on Keystone Symposia and the Antibodies as Drugs Conference here.  

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.